Binkert Franz, Mutter Michael, Schinzel Albert
Institute of Medical Genetics, University of Zurich, Switzerland.
Swiss Med Wkly. 2002 Aug 24;132(33-34):478-84. doi: 10.4414/smw.2002.10009.
To investigate the impact of prenatal diagnosis on trisomy 21 live births, we collected all prenatal and postnatal trisomy 21 cases (n = 1096) in the eastern half of Switzerland for the years 1980-1996.
Despite increasing prenatal detection rates of trisomy 21 foetuses (an increase of 169% in the last 5 versus the first 5 years of the study period) and subsequent termination of pregnancies, the number of liveborn Down syndrome children remained constant. The reason is a shift towards a higher mean maternal age from 28 to 30 years between 1980 and 1996. If mean maternal age at delivery was considered, the observed increase of trisomy 21 conceptions matched well with the calculated figures.
If the tendency to have pregnancies at a more advanced age continues and if the use of prenatal diagnosis does not increase, an increase in incidence of Down syndrome liveborns may be expected in the first decades of the 21st century.
为研究产前诊断对21三体活产儿的影响,我们收集了1980 - 1996年瑞士东半部所有产前及产后21三体病例(n = 1096)。
尽管21三体胎儿的产前检测率有所上升(研究期最后5年与最初5年相比增加了169%),且随后终止了妊娠,但唐氏综合征活产儿的数量保持不变。原因是1980年至1996年间产妇平均年龄从28岁上升至30岁。如果考虑分娩时的产妇平均年龄,观察到的21三体妊娠增加情况与计算数字非常吻合。
如果高龄妊娠的趋势持续,且产前诊断的应用没有增加,预计在21世纪的头几十年,唐氏综合征活产儿的发病率将会上升。